Clinical Trial Detail

NCT ID NCT03917381
Title GEN1046 Safety Trial in Patients With Malignant Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Genmab
Indications

transitional cell carcinoma

head and neck squamous cell carcinoma

triple-receptor negative breast cancer

endometrial carcinoma

lung non-small cell carcinoma

cervical cancer

Advanced Solid Tumor

Therapies

GEN1046

Age Groups: adult senior

No variant requirements are available.